QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling 收藏  |  浏览/下载：45/0  |  提交时间：2021/11/01 Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文 GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162 作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin 收藏  |  浏览/下载：42/0  |  提交时间：2021/11/01 Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer 期刊论文 JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2021, 卷号: 17, 期号: 8, 页码: 1486-1509 作者:  Wang, Jiaxin;  Zhou, Mengxue;  Chen, Fangmin;  Liu, Xiao;  Gao, Jin 收藏  |  浏览/下载：41/0  |  提交时间：2021/11/04 Cancer Immunotherapy  Tumor Microenvironment  Stimuli-Responsiveness  Sheddable Nanoparticles  Pathophysiological Barriers   Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin 收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10 Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin 收藏  |  浏览/下载：23/0  |  提交时间：2022/01/10